Publicacións en colaboración con investigadores/as de Cleveland Clinic (5)

2023

  1. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

2021

  1. Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis

    JCI Insight, Vol. 6, Núm. 11

2019

  1. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    The Lancet Oncology, Vol. 20, Núm. 10, pp. e566-e581

  2. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357

2014

  1. Negative regulation of the interferon response by an interferon-induced long non-coding RNA

    Nucleic Acids Research, Vol. 42, Núm. 16, pp. 10668-10681